mRNA |
TAE684 |
CTRPv2 |
pan-cancer |
AAC |
0.088 |
0.01 |
mRNA |
OSI-930 |
CTRPv2 |
pan-cancer |
AAC |
-0.091 |
0.01 |
mRNA |
thalidomide |
CTRPv2 |
pan-cancer |
AAC |
0.13 |
0.01 |
mRNA |
docetaxel:tanespimycin (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.08 |
0.01 |
mRNA |
PD 153035 |
CTRPv2 |
pan-cancer |
AAC |
0.1 |
0.01 |
mRNA |
LY-2183240 |
CTRPv2 |
pan-cancer |
AAC |
-0.078 |
0.01 |
mRNA |
Bosutinib |
CTRPv2 |
pan-cancer |
AAC |
-0.085 |
0.01 |
mRNA |
cyanoquinoline 11 |
CTRPv2 |
pan-cancer |
AAC |
-0.12 |
0.01 |
mRNA |
ISOX:bortezomib (250:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.085 |
0.01 |
mRNA |
tivantinib |
CTRPv2 |
pan-cancer |
AAC |
-0.11 |
0.01 |